BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 23414091)

  • 1. Age-related oxidative modifications of transthyretin modulate its amyloidogenicity.
    Zhao L; Buxbaum JN; Reixach N
    Biochemistry; 2013 Mar; 52(11):1913-26. PubMed ID: 23414091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.
    Penchala SC; Connelly S; Wang Y; Park MS; Zhao L; Baranczak A; Rappley I; Vogel H; Liedtke M; Witteles RM; Powers ET; Reixach N; Chan WK; Wilson IA; Kelly JW; Graef IA; Alhamadsheh MM
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9992-7. PubMed ID: 23716704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloidogenic and non-amyloidogenic transthyretin variants interact differently with human cardiomyocytes: insights into early events of non-fibrillar tissue damage.
    Manral P; Reixach N
    Biosci Rep; 2015 Jan; 35(1):. PubMed ID: 25395306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs.
    Bourgault S; Choi S; Buxbaum JN; Kelly JW; Price JL; Reixach N
    Biochem Biophys Res Commun; 2011 Jul; 410(4):707-13. PubMed ID: 21557933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice?
    Zhang Q; Kelly JW
    Biochemistry; 2005 Jun; 44(25):9079-85. PubMed ID: 15966731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of a gatekeeper residue on the aggregation of transthyretin: implications for transthyretin-related amyloidoses.
    Sant'Anna R; Braga C; Varejão N; Pimenta KM; Graña-Montes R; Alves A; Cortines J; Cordeiro Y; Ventura S; Foguel D
    J Biol Chem; 2014 Oct; 289(41):28324-37. PubMed ID: 25086037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease.
    McCutchen SL; Lai Z; Miroy GJ; Kelly JW; Colón W
    Biochemistry; 1995 Oct; 34(41):13527-36. PubMed ID: 7577941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the structure, thermodynamic stability, and aggregation properties of the A25T transthyretin (A25T-TTR) variant involved in leptomeningeal amyloidosis: identifying protein partners that co-aggregate during A25T-TTR fibrillogenesis in cerebrospinal fluid.
    Azevedo EP; Pereira HM; Garratt RC; Kelly JW; Foguel D; Palhano FL
    Biochemistry; 2011 Dec; 50(51):11070-83. PubMed ID: 22091638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis.
    Saito S; Ando Y; Nakamura M; Ueda M; Kim J; Ishima Y; Akaike T; Otagiri M
    Biochemistry; 2005 Aug; 44(33):11122-9. PubMed ID: 16101296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes.
    Sartiani L; Bucciantini M; Spinelli V; Leri M; Natalello A; Nosi D; Maria Doglia S; Relini A; Penco A; Giorgetti S; Gerace E; Mannaioni G; Bellotti V; Rigacci S; Cerbai E; Stefani M
    Biophys J; 2016 Nov; 111(9):2024-2038. PubMed ID: 27806283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis.
    Hurshman Babbes AR; Powers ET; Kelly JW
    Biochemistry; 2008 Jul; 47(26):6969-84. PubMed ID: 18537267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants.
    Miller SR; Sekijima Y; Kelly JW
    Lab Invest; 2004 May; 84(5):545-52. PubMed ID: 14968122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.
    Foguel D; Suarez MC; Ferrão-Gonzales AD; Porto TC; Palmieri L; Einsiedler CM; Andrade LR; Lashuel HA; Lansbury PT; Kelly JW; Silva JL
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9831-6. PubMed ID: 12900507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.
    Sato T; Ando Y; Susuki S; Mikami F; Ikemizu S; Nakamura M; Suhr O; Anraku M; Kai T; Suico MA; Shuto T; Mizuguchi M; Yamagata Y; Kai H
    FEBS Lett; 2006 Jan; 580(2):491-6. PubMed ID: 16386248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nearly 200 X-ray crystal structures of transthyretin: what do they tell us about this protein and the design of drugs for TTR amyloidoses?
    Palaninathan SK
    Curr Med Chem; 2012; 19(15):2324-42. PubMed ID: 22471981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stilbene Boronic Acids Form a Covalent Bond with Human Transthyretin and Inhibit Its Aggregation.
    Smith TP; Windsor IW; Forest KT; Raines RT
    J Med Chem; 2017 Sep; 60(18):7820-7834. PubMed ID: 28920684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative stabilization of transthyretin by clusterin and diflunisal.
    Greene MJ; Klimtchuk ES; Seldin DC; Berk JL; Connors LH
    Biochemistry; 2015 Jan; 54(2):268-78. PubMed ID: 25478940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression.
    Sekijima Y; Dendle MT; Wiseman RL; White JT; D'Haeze W; Kelly JW
    Amyloid; 2006 Jun; 13(2):57-66. PubMed ID: 16911959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: insights from molecular dynamics simulations.
    Rodrigues JR; Simões CJ; Silva CG; Brito RM
    Protein Sci; 2010 Feb; 19(2):202-19. PubMed ID: 19937650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions.
    Zhang Q; Kelly JW
    Biochemistry; 2003 Jul; 42(29):8756-61. PubMed ID: 12873136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.